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Primary pigmented tumors in the cerebellopontine angle
(CPA) are uncommon and include pigmented meningiomas,
melanocytic colonization of meningothelial meningioma,
malignantmelanomas,meningealmelanocytomas,melanotic
schwannomas, and melanoblastosis. The differential diagno-
sis is often confusing owing to their similar appearance on
preoperative investigations and similar histological features.
Hence, conﬁrmation by electronmicroscopy (EM) and immu-
nohistochemical tests are required. As the biological behav-
ior, treatment, and prognosis of these lesions vary markedly,
it is important to make the correct pathologic diagnosis.
Melanocytomas are slow-growing tumors of melanocytes.
They compress rather than inﬁltrate adjacent tissues. Mela-
nocytes are normally found in human leptomeninges,1 and
are thought to originate from the neural crest found within
the basal layer of the epidermis and the leptomeninges
covering the base of the brain and the brainstem.2–4 Conse-
quently, pigmented intracranial tumors most commonly
involve pons, cerebellum, cerebral peduncles, medulla, inter-
peduncular fossa, and inferior surfaces of the cerebrum.3–5
These neoplasms are generally divided into diffusemelanosis,
meningeal melanocytomas, and primary malignant
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Abstract Introduction Primary cerebellopontine angle melanocytomas (PCPAMs) are very rare.
Their natural history and prognosis are not fully understood. We reviewed the literature
and add a new case to analyze PCPAM's presentation, radiological features, and outcome
of treatment.
Methods We performed a literature review using Medline, Embase, PubMed, and
Cochrane databases. We searched for melanocytoma, melanoma, and pigmented
tumors in the posterior cranial fossa and CPA to identify PCPAM. We have also searched
our institution's neuro-oncology database.
Results We identiﬁed 23 PCPAM from the literature and one case of our own. The
mean age at presentation was 44.4 years with slight male preponderance. PCPAM
presented with cerebellopontine angle (CPA) syndrome with or without hydrocephalus.
Preoperative diagnosis was difﬁcult; they appeared hyperintense on T1 and isointense
on T2 magnetic resonance imaging (MRI) and enhanced with gadolinium. However, the
ﬁnal diagnosis was only made by immunohistochemical examination. Total surgical
resection of PCPAM was associated with prolonged survival while subtotal excision was
associated with frequent recurrence.
Conclusion PCPAM are very rare and should be considered in the differential diagnosis
of all CPA lesions that appear hyperintense on T1 and isointense on T2 MRI images.
Patients with PCPAM should undergo total surgical resection to avoid fatal recurrences.
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melanomas. Limas and Tio2 coined the term meningeal
melanocytoma after observing melanosomes and premela-
nosomes in tumor cells of a heavily pigmented foramen
magnum tumor. Primarymelanocytomas have been reported
to be more common in men. We add another case and review
the literature to establish clinical, radiological and histopath-
ological features, treatment, and prognosis of these rare
tumors.
Methods
We reviewed Medline, Embase, PubMed, and the Cochrane
databases to identify all patients who had rimary cerebello-
pontine angle melanocytoma (PCPAM). We searched the
following terms: melanocytoma, pigmented tumors, and
melanoma combined with posterior cranial fossa or CPA.
We included only those tumors that fulﬁlled the diagnostic
criteria for primary melanocytoma and those located in the
CPA. The clinical presentation, radiological features, histolog-
ical ﬁndings, treatment, and the outcome of the treatment of
these patients were collated and analyzed to document
PCPAM's behavior and outcome.
We also reviewed our neuro-oncology and neuropatholo-
gy databases to look for any PCPAM in our institution.
The collated data were analyzed using simple statistics to
determine frequencies, means, medians, and rates.
Case Report
A 40-year-old man presented with occipital headaches asso-
ciated with nausea. On examination he displayed truncal
ataxia, The new clinical signs were sensory neural deafness
on the right and ataxia. His magnetic resonance imaging
(MRI) brain scan demonstrated a solitary lesion arising in
the right para-pontine space and CPA. It appeared to be extra-
axial with mass effect and normal internal auditory meatus
appearance. On T2W the lesion was mixed appearance:
isointense, hyperintense, and areas of hypointensity
(►Fig. 1A). On T1W the lesion appeared hyperintense with
areas of isointensity (►Fig. 1B). The lesion enhanced after
gadolinium administration (►Fig. 1C).
Operation
The patient underwent a posterior fossa craniotomy. The
craniotomy was performed via retro-sigmoid approach
with the intent of total removal. The seventh cranial nerve
was monitored during surgery but the eighth was not moni-
tored because he was profoundly deaf on the right. At opera-
tion a purplish-pink friable tumor involving the right CPA,
extending down to the foramen magnum inferiorly was
found. This was dissected gradually and removed using an
ultrasonic dissector and microsurgery. However, the tumor
was found to be invading the brainstem and the surrounding
structures, encasing the right vertebral artery. Hence only
subtotal excision was possible. Postoperatively, the patient
had excellent postoperative recovery with Karnofsky perfor-
mance score of 80. He proceeded to 4-week course of radio-
therapy and was seen in the clinic with satisfactory
postoperative progress. Histologically tumor cells appeared
relatively uniform, andwere arranged in solid lobuleswith no
evidence of necrosis. The nuclei were rounded and exhibited
a mild degree of pleomorphism, with rounded nucleoli
(►Fig. 2A). Granular brown pigment was present in occasion-
al tumor cells and in macrophages around the tumor lobules
that gave a positive reaction for melanin on a Singh stain.
Immunohistochemistry for Melan-A (►Fig. 2B), HMB45, and
neurone-speciﬁc enolase was strongly positive. A stain for
S-100 protein was weakly positive. These ﬁndings indicated
that this was a melanocytic lesion, rather than a melanotic
Figure 1 Magnetic resonance imaging scan of primary cerebello-
pontine angle melanocytoma. (A) Axial T2 image showing a right
cerebellopontine angle (CPA) isointense mass and areas of hypo and
hyper intensity. (B) Coronal T1 image showing a right CPA mass
displacing the brainstem. The lesion was slightly hyperintense with
areas of isointensity. (C) Axial T1 with contrast demonstrating mild
homogeneous enhancement.
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Schwannoma. Mitotic activity was not a prominent feature
(<1%) and the cell proliferation indexon a Ki-67 immunostain
was low (<5%) (►Fig. 2C). The relative lack of mitotic activity,
necrosis, and pleomorphism, along with a low cellular pro-
liferation index, favored a diagnosis of melanocytoma rather
than malignant melanoma. After 3.5 years of initial presen-
tation, tumor progression was detected on MRI surveillance
and further surgery was undertaken. Histological analysis of
the second specimen demonstrated similar appearances to
the initial specimen (few mitotic ﬁgures (<1%) and a Ki-67
proliferation index of <5%), with no evidence of malignant
transformation. However, the patient succumbed to unrelat-
ed causes 6 weeks later.
Results
We collected 23 PCPAM from the literature and one PCPAM
from our own database. There were enough data on each case
to include in our analysis (►Table 1). The mean age at
presentation was 44.4 years (range: 9 to 71 years), men
were affected more commonly than women 7:5. Between
the ages of 30 to 60 years menwere affected twice as women.
The most common presenting symptom was headache
(58%), dysphagia, ataxia, and vomiting was noted in 29%,
diplopia and sensory deafness in 25%, facial numbness,
papilledema and leg weakness in 21%, neck pain in 8%, and
syncope in 4%. The median duration of symptoms was
5 months (range: few weeks to 14 years).
MRI characteristically demonstrated hyperintensity on
T1-weighted images and hypo- or isointensity on T2-weight-
ed images. These tumors usually enhanced homogenously
with gadolinium. Histologically, PCPAM appeared as shown
in ►Fig. 2.
Twelve patients had total surgical resection (11 in one
stage and 1 in two stages) with median follow-up of 4 years
with no deaths. Early recurrence was reported at 8 months in
one case (8%). Late recurrencewas reported in two cases: one
after 8 years and the other after 10.8 years. All three recur-
rences diedwithin 12months from recurrence irrespective of
treatment. Only 1 of 12 totally resected PCPAM had adjuvant
radiotherapy. Nine patients had subtotal removal. Five pa-
tients had subtotal removal with 1 month to 3.5 years follow-
up with 1 early death (20%), two progressed within months
(40%),and one died within a year (20%). A total of 80% of
subtotal resections either progressed or died within
12 months of diagnosis. One subtotal resection had no
follow-up information. Three had subtotal resection followed
by radiotherapy; one died after 6 months due to hemorrhage,
one had no recurrence at 2 years and the third recurred at
3 years and died at 3.5 years. One patient only had biopsy and
died within 3 days of surgery, and one patient had diagnosis
made at autopsy.
Discussion
Primary CPA melanocytomas are very rare tumors and it is
unlikely one center or one team will have sufﬁcient numbers
to establish their behavior, prognosis, or best treatment. Our
review revealed peak incidence between 30 and 60 years of
age and preponderance in males, but they can present at any
age. The duration of symptoms varied widely, from 3 months
to 14 years. PCPAM presented with symptoms and signs of an
expandingmass in the posterior cranial fossa, andmay lead to
Figure 2 Histological features of melanocytoma. All original magni-
ﬁcations are x200. (A) Hematoxylin and eosin stain demonstrating
solid lobules of uniform cells with scanty pigment (mostly in macro-
phages) and rounded nuclei. (B) Immunocytochemistry for Melan-A
showing strong cytoplasmic positivity, conﬁrming the melanocytic
nature and helping to exclude meningioma and schwannoma.
(C) Immunocytochemistry for Ki-67 revealing a low proliferation index
( 5%) which would be unusual in a primary or metastatic malignant
melanoma.
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obstructive hydrocephalus or cerebellar dysfunction.6,7 These
symptoms and signs are similar to other lesions in the same
anatomical location, acoustic neuroma, meningioma, metas-
tasis, and epidermoid cysts.
Although preoperative diagnosiswas notmade in all cases,
a high index of suspicion is the key to clinch the diagnosis
preoperatively. MRI characteristically demonstrated hyper-
intensity on T1-weighted images and hypo- or isointensity on
T2-weighted images.6,8–10 These tumors enhanced homoge-
nously with gadolinium. The lack of characteristic hyper-
intensity on T2-weighted imaging may possibly be due to
their cellular or ﬁbrous nature, resulting in diminished water
content, paramagnetic effects of melanin, susceptibility arti-
facts or possibly hemorrhage.
The diagnosis is often made on immunohistochemistry
and EM. PCPAMs are strongly immunoreactive to S-100
protein, HMB-45 and vimentin and, are nonreactive to epi-
thelial membrane antigen and glial ﬁbrillary acid pro-
teins.9,11–13 EM of melanocytomas demonstrate small
smooth nuclei, indstinct nucleoli, abundant cytoplasm, and
elaborate cytoplasmic processes. There is no external lamina
around cytoplasmic membranes, no micropinocytotic
vesicles and absent junctional complexes, and interdigitation
of apposing cells. Our patient did not have EM examination
because our pathologist was quite happy with the diagnosis
without EM, however, if there was a doubt EM would be
helpful. PCPAM must be distinguished from other histologi-
cally similar lesions of the central nervous system, such as
melanotic schwannomas and meningiomas,9,11,14 metastatic
or primary malignant melanoma, meningeal melanocytic
naevi, pigmented neuroﬁbromas, and pigmented primitive
neuroectodermal tumors.
Although PCPAM and primary malignant melanomas of
the leptomeninges originate from leptomeningeal melano-
cytes, they are different in appearance and behavior.14–19
PCPAMs have a much better prognosis than their malignant
counterparts. Although most authors consider PCPAMs to be
benign tumors, however melanocytomas in other locations
such as the spinal cord tended to recur after resection and can
be locally aggressive.9,12,20–24 As such some consider PCPAMs
to be borderline tumors with guarded prognosis.9,12,21
Surgical resection had resulted in prolonged remission for
up to 35 years,25 which justiﬁes an aggressive surgical
management.8,12,25,26 However, early recurrence was re-
ported in 8% and late recurrence in 16% with fatal conse-
quences. Incomplete resection invariably resulted into tumor
progression with fatal consequences. Postoperative radiation
therapy had been used in four patients; in one patient after
complete resection who was alive and well 7 years after
diagnosis, and in three patients after subtotal removal, one
died from hemorrhage within 6 months, one recurred after
3 years and the third was alive and well 2 years after
treatment.26,27 Hamasaki et al and Kurita et al treated pa-
tients with meningeal melanocytoma after partial surgical
resection by radiosurgery with good early results.28,29 There
was only one report in which chemotherapy was used in the
management of spinal melanocytoma with time to tumor
progression of 15 months.30 None of the reported cases
metastasized implying that PCPAM are locally invasive tu-
mors in which patients succumb to local recurrence and
invasion rather than distant metastases.
Conclusion
PCPAMs are very rare tumors and often misdiagnosed pre-
operatively. They are generally benign tumors and well-
differentiated histologically. They should be considered in
the differential diagnosis of tumors of the posterior cranial
fossa. Complete surgical resection is associated with better
outcome. The role of radiotherapy, radiosurgery, and chemo-
therapy is undetermined even when surgical resection was
incomplete. Further documentation of these rare tumors and
worldwide tumor registry is essential to study their behavior
and ﬁnd the best treatment paradigm.
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